Pharma

Your Article Summary

See Latest Articles

European CHMP Adopts Positive Opinion for Aztreonam Lysine
Gilead, 06/29/09

Gilead Sciences, Inc. announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has adopted a positive opinion on the company's Marketing Authorisation Application for aztreonam lysine 75 mg powder and solvent for nebuliser solution for the suppressive therapy of chronic pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis aged 18 years and older. The opinion is for conditional approval, contingent on the successful completion of an ongoing study.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
ImmunoGen, Inc., 11/25/09

AMA meeting: Nap time mandate for on-call residents rejected
American Medical News , 11/25/09

AMA meeting: Delegate vote refines AMA stance on system reform
American Medical News , 11/25/09

 See all of Conferences/Meetings

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09

Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09

 See all of Marketing/Media/ROI